共 50 条
- [31] A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphomaFRONTIERS IN ONCOLOGY, 2024, 14论文数: 引用数: h-index:机构:Jang, Suk-Chan论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South KoreaKang, Dong-Won论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea论文数: 引用数: h-index:机构:Koh, Hyein论文数: 0 引用数: 0 h-index: 0机构: Novartis, Seoul, South Korea Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea论文数: 引用数: h-index:机构:Park, Mi-Hai论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea
- [32] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective StudyINDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2022, 38 (01) : 42 - 50Ren, Liangliang论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaLi, Ling论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaZhang, Lei论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaLi, Xin论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaFu, Xiaorui论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaWang, Xinhua论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaWu, Jingjing论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaSun, Zhenchang论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaFeng, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaChang, Yu论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaZhou, Zhiyuan论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaNan, Feifei论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaYan, Jiaqin论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaKong, Fei论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R ChinaZhang, Mingzhi论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China Zhengzhou Univ, Dept Oncol, Lymphoma Diag & Treatment Ctr Henan Prov, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
- [33] A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patientsASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (02) : E11 - E16Jiang, Shiyu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaQin, Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaLiu, Peng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaYang, Jianliang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaYang, Sheng论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaHe, Xiaohui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaZhou, Shengyu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaGui, Lin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaZhang, Changgong论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaZhou, Liqiang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaSun, Yan论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R ChinaShi, Yuankai论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China Chinese Acad Med Sci, Dept Med Oncol, Beijing Key Lab Clin Study Anticanc Mol Targeted, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
- [34] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphomaSWISS MEDICAL WEEKLY, 2020, : 21S - 21SDietliker, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, SwitzerlandKiesel, H.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, SwitzerlandMueller, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, SwitzerlandMueller, A. M.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, SwitzerlandManz, M. G.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, SwitzerlandZenz, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, SwitzerlandRosler, W.论文数: 0 引用数: 0 h-index: 0机构: Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland Univ Spital Zurich, Klin Med Onkol & Hamatol, Zurich, Switzerland
- [35] Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective StudyIndian Journal of Hematology and Blood Transfusion, 2022, 38 : 42 - 50Liangliang Ren论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceLing Li论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceLei Zhang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceXin Li论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceXiaorui Fu论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceXinhua Wang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceJingjing Wu论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceZhenchang Sun论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceXiaoyan Feng论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceYu Chang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceZhiyuan Zhou论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceFeifei Nan论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceJiaqin Yan论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceFei Kong论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan ProvinceMingzhi Zhang论文数: 0 引用数: 0 h-index: 0机构: The First Affiliated Hospital of Zhengzhou University,Department of Oncology, Lymphoma Diagnosis and Treatment Center of Henan Province
- [36] DeVIC chemotherapy is effective for patients with refractory or relapsed diffuse large B-cell lymphomaANNALS OF ONCOLOGY, 2015, 26 : 108 - 108Okada, Kazuya论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanSakai, Kazuya论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanMuranushi, Hiroyuki论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanOkamoto, Yusuke论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanSugiura, Hiroyuki论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanSato, Aki论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanSato, Takayuki论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanMaeda, Takeshi论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanOnishi, Tatsuhito论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, JapanUeda, Yasunori论文数: 0 引用数: 0 h-index: 0机构: Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan Kurashiki Cent Hosp, Dept Haematol Oncol, Kurashiki, Okayama, Japan
- [37] Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphomaCURRENT ONCOLOGY, 2019, 26 (04) : 253 - 265Skrabek, R.论文数: 0 引用数: 0 h-index: 0机构: CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada Univ Manitoba, Dept Hematol & Med Oncol, Winnipeg, MB, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaAssouline, S.论文数: 0 引用数: 0 h-index: 0机构: Sir Mortimer B Davis Jewish Hosp, Div Hematol, Dept Med, Montreal, PQ, Canada McGill Univ, Montreal, PQ, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaChristofides, A.论文数: 0 引用数: 0 h-index: 0机构: IMPACT Medicom Inc, Toronto, ON, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaMacDonald, D.论文数: 0 引用数: 0 h-index: 0机构: Ottawa Hosp, Ottawa, ON, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaPrica, A.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada Univ Toronto, Toronto, ON, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaSangha, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Alberta, Edmonton, AB, Canada Cross Canc Inst, Edmonton, AB, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaMatthews, B. A.论文数: 0 引用数: 0 h-index: 0机构: Hoffmann La Roche, Mississauga, ON, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, CanadaSehn, L. H.论文数: 0 引用数: 0 h-index: 0机构: Univ British Columbia, Div Med Oncol, Vancouver, BC, Canada BC Canc, Vancouver, BC, Canada CancerCare Manitoba, 675 McDermot Ave, Winnipeg, MB R3E 0V9, Canada
- [38] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell LymphomaNEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01): : 45 - 56Schuster, Stephen J.论文数: 0 引用数: 0 h-index: 0机构: Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USABishop, Michael R.论文数: 0 引用数: 0 h-index: 0机构: Univ Chicago Med, Hematopoiet Cellular Therapy Program, Chicago, IL USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USATam, Constantine S.论文数: 0 引用数: 0 h-index: 0机构: St Vincents Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia Univ Melbourne, Melbourne, Vic, Australia Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAWaller, Edmund K.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Bone Marrow & Stem Cell Transplant Ctr, Atlanta, GA 30322 USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USABorchmann, Peter论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Cologne, Dept Hematol & Oncol, Cologne, Germany Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAMcGuirk, Joseph P.论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Ctr Canc, Div Hematol Malignancies & Cellular Therapeut, Kansas City, KS USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAJaeger, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA论文数: 引用数: h-index:机构:Andreadis, Charalambos论文数: 0 引用数: 0 h-index: 0机构: Univ Calif San Francisco, Dept Hematol & Blood & Marrow Transplant, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAWestin, Jason R.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Div Canc Med, Houston, TX 77030 USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAFleury, Isabelle论文数: 0 引用数: 0 h-index: 0机构: Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USABachanova, Veronika论文数: 0 引用数: 0 h-index: 0机构: Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAFoley, S. Ronan论文数: 0 引用数: 0 h-index: 0机构: Juravinski Hosp, Hamilton, ON, Canada McMaster Univ, Ctr Canc, Hamilton, ON, Canada Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAHo, P. Joy p论文数: 0 引用数: 0 h-index: 0机构: Royal Prince Alfred Hosp, Sydney, NSW, Australia Univ Sydney, Dept Med, Sydney, NSW, Australia Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAMielke, Stephan论文数: 0 引用数: 0 h-index: 0机构: Wurzburg Univ, Med Ctr, Ctr Allogene Stem Cell Transplantat, Wurzburg, Germany Karolinska Inst, Stockholm, Sweden Univ Hosp, Dept Lab Med, Dept Cell Therapy & Allogene Stem Cell Transplant, Stockholm, Sweden Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAMagenau, John M.论文数: 0 引用数: 0 h-index: 0机构: Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAHolte, Harald论文数: 0 引用数: 0 h-index: 0机构: Oslo Univ Hosp, Dept Oncol, Oslo, Norway Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAPantano, Serafino论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Basel, Switzerland Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAPacaud, Lida B.论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAAwasthi, Rakesh论文数: 0 引用数: 0 h-index: 0机构: Novartis Inst BioMed Res, E Hanover, NJ USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAChu, Jufen论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAAnak, Ozlem论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, Basel, Switzerland Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USASalles, Gilles论文数: 0 引用数: 0 h-index: 0机构: Univ Lyon, Hosp Civils Lyon, Dept Hematol, Lyon, France Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USAMaziarz, Richard T.论文数: 0 引用数: 0 h-index: 0机构: Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Hematol Malignancies, Portland, OR 97201 USA Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA
- [39] Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell LymphomaINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 12Harris, Leonard Jeff论文数: 0 引用数: 0 h-index: 0机构: Univ Tennessee, Dept Med, Oncol Div, Hlth Sci Ctr, Memphis, TN 38103 USA Univ Tennessee, Dept Med, Oncol Div, Hlth Sci Ctr, Memphis, TN 38103 USA论文数: 引用数: h-index:机构:Martin, Michael论文数: 0 引用数: 0 h-index: 0机构: West Canc Ctr & Res Inst, Memphis, TN 38103 USA Univ Tennessee, Dept Med, Oncol Div, Hlth Sci Ctr, Memphis, TN 38103 USA
- [40] Phylogenetic Evolution in Refractory/Relapsed Diffuse Large B-Cell LymphomaBLOOD, 2012, 120 (21)Ruminy, Philippe论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, France INSERM, U918, Rouen, FranceRainville, Vinciane论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, FranceMareschal, Sylvain论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, FranceEtancelin, Pascaline论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, France INSERM, U918, Rouen, FranceJoly, Berangere论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, FrancePicquenot, Jean-Michel论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, FranceBastard, Christian论文数: 0 引用数: 0 h-index: 0机构: Ctr Henri Becquerel, Lab Hematol & Mol Biol, F-76038 Rouen, France INSERM, U918, Rouen, FranceTilly, Herve论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, FranceJardin, Fabrice论文数: 0 引用数: 0 h-index: 0机构: INSERM, U918, Rouen, France INSERM, U918, Rouen, France